Cencora, Inc. $COR Shares Purchased by Simon Quick Advisors LLC

Simon Quick Advisors LLC increased its position in shares of Cencora, Inc. (NYSE:COR) by 21.4% in the 2nd quarter, Holdings Channel.com reports. The firm owned 1,547 shares of the company’s stock after acquiring an additional 273 shares during the quarter. Simon Quick Advisors LLC’s holdings in Cencora were worth $464,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Atlantic Edge Private Wealth Management LLC increased its holdings in shares of Cencora by 70.0% during the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 85 shares of the company’s stock worth $25,000 after buying an additional 35 shares during the last quarter. Cornerstone Planning Group LLC increased its stake in Cencora by 106.7% during the first quarter. Cornerstone Planning Group LLC now owns 93 shares of the company’s stock worth $26,000 after acquiring an additional 48 shares during the last quarter. Costello Asset Management INC acquired a new stake in Cencora during the first quarter worth $28,000. University of Texas Texas AM Investment Management Co. acquired a new stake in Cencora during the first quarter worth $39,000. Finally, Olde Wealth Management LLC acquired a new stake in Cencora during the first quarter worth $48,000. Institutional investors and hedge funds own 97.52% of the company’s stock.

Insider Buying and Selling at Cencora

In related news, CEO Robert P. Mauch sold 5,097 shares of the business’s stock in a transaction on Monday, October 20th. The stock was sold at an average price of $326.80, for a total transaction of $1,665,699.60. Following the completion of the transaction, the chief executive officer directly owned 37,940 shares of the company’s stock, valued at $12,398,792. The trade was a 11.84% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Chairman Steven H. Collis sold 31,350 shares of the business’s stock in a transaction on Tuesday, September 16th. The stock was sold at an average price of $289.86, for a total value of $9,087,111.00. Following the transaction, the chairman directly owned 305,913 shares of the company’s stock, valued at $88,671,942.18. The trade was a 9.30% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 41,544 shares of company stock valued at $12,230,941. Insiders own 10.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on COR. Weiss Ratings reissued a “buy (b-)” rating on shares of Cencora in a research report on Thursday. Mizuho lifted their price target on shares of Cencora from $334.00 to $340.00 and gave the company an “outperform” rating in a research report on Thursday. UBS Group lifted their price target on shares of Cencora from $350.00 to $380.00 and gave the company a “buy” rating in a research report on Monday, October 27th. Morgan Stanley set a $330.00 target price on shares of Cencora and gave the company an “equal weight” rating in a report on Wednesday, July 16th. Finally, Wall Street Zen downgraded shares of Cencora from a “buy” rating to a “hold” rating in a report on Saturday, October 11th. Nine research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $329.55.

Cencora Stock Performance

NYSE COR opened at $337.60 on Friday. The company has a debt-to-equity ratio of 3.64, a current ratio of 0.90 and a quick ratio of 0.53. The company has a market cap of $65.45 billion, a P/E ratio of 34.73, a P/E/G ratio of 1.56 and a beta of 0.63. The stock has a 50-day moving average of $308.09 and a two-hundred day moving average of $297.11. Cencora, Inc. has a 1-year low of $223.92 and a 1-year high of $350.46.

Cencora (NYSE:COR) last announced its quarterly earnings data on Wednesday, August 6th. The company reported $4.00 earnings per share for the quarter, beating analysts’ consensus estimates of $3.79 by $0.21. The firm had revenue of $80.66 billion during the quarter, compared to analysts’ expectations of $80.34 billion. Cencora had a net margin of 0.60% and a return on equity of 267.36%. The business’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $3.34 earnings per share. As a group, analysts anticipate that Cencora, Inc. will post 15.37 EPS for the current year.

Cencora Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 3rd. Shareholders of record on Friday, August 15th were paid a $0.55 dividend. The ex-dividend date was Friday, August 15th. This represents a $2.20 annualized dividend and a dividend yield of 0.7%. Cencora’s payout ratio is 22.63%.

About Cencora

Cencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.